object
studi
evalu
effect
supplement
blend
prebiot
probiot
hyperimmun
dri
egg
protein
perform
health
innat
immun
respons
holstein
calv
first
age
nineti
dayold
holstein
bull
calv
complet
random
treatment
group
prophylact
control
prophylact
calv
proprietari
blend
prebiot
probiot
hyperimmun
egg
protein
calfpro
plu
calf
life
c
e
agri
product
baldwin
nd
ad
directli
milk
replac
feed
control
calv
fed
milk
replac
treatment
influenc
perform
holstein
calv
among
calv
voluntarili
refus
milk
replac
prophylact
calv
refus
less
p
control
calv
first
life
prophylact
treatment
reduc
incid
enter
morbid
vs
prophylact
control
calv
respect
p
howev
treatment
influenc
either
total
peripher
leukocyt
differenti
count
furthermor
hematocrit
plasma
concentr
haptoglobin
cortisol
glucos
urea
nitrogen
differ
treatment
last
ex
vivo
innat
immun
respons
evalu
age
differ
treatment
calv
fed
combin
prebiot
probiot
hyperimmun
egg
protein
reject
less
milk
replac
first
experi
fewer
day
enter
morbid
control
calv
risk
morbid
mortal
among
dairi
calv
due
enter
infect
high
dairi
calf
morbid
mortal
reduc
perform
enhanc
antibiot
oxytetracyclin
neomycin
includ
milk
replac
quigley
et
al
howev
concern
use
antimicrobi
livestock
industri
caus
increas
antibioticresist
bacteria
caus
diseas
human
therefor
altern
use
metaphalact
antimicrobi
need
interest
use
prebiot
probiot
dri
egg
protein
hyperimmun
lay
hen
improv
enter
health
calv
abe
et
al
ikemori
et
al
heinrich
et
al
probiot
live
nonpathogen
microorgan
colon
gastrointestin
tract
wherea
prebiot
nondigest
dietari
compon
stimul
microorgan
growth
gastrointestin
tract
immun
lay
hen
variou
epitop
pathogen
relev
microorgan
increas
concentr
igyspecif
antibodi
whole
dri
egg
hennigpauka
et
al
influenc
prebiot
probiot
health
dairi
calv
equivoc
research
show
profession
anim
scientist
case
studi
effect
blend
prebiot
probiot
hyperimmun
dri
egg
protein
perform
health
innat
immun
respons
holstein
calv
duce
scour
improv
perform
abe
et
al
heinrich
et
al
wherea
data
show
benefit
includ
either
prebiot
probiot
milk
replac
morril
et
al
hill
et
al
inclus
whole
dri
egg
hyperimmun
hen
decreas
morbid
due
variou
bacteria
hennigpauka
et
al
virus
kuroki
et
al
ikemori
et
al
object
current
studi
evalu
effect
supplement
blend
prebiot
probiot
hyperimmun
dri
egg
protein
perform
health
innat
immun
respons
holstein
calv
first
wk
life
anim
care
use
approv
anim
care
use
committe
texa
tech
univers
experi
conduct
februari
nineti
holstein
bull
calv
h
birth
acquir
daili
local
commerci
dairi
herd
period
calv
fed
l
pool
colostrum
dairi
within
h
birth
calv
transport
approxim
km
hilmar
chees
calf
research
facil
texa
tech
univers
new
deal
texa
calv
hous
individu
commerci
polyethylen
calf
hutch
agriplast
tonawanda
ny
bed
straw
upon
arriv
research
facil
calv
weigh
ml
peripher
blood
collect
jugular
venipunctur
quantif
total
serum
protein
use
temperaturecontrol
refractomet
within
dairi
sourc
calv
complet
random
treatment
group
includ
neg
control
control
prophylact
treatment
prophylact
n
calvestreat
group
assign
treatment
prophylact
calv
administ
onetim
oral
bolu
ml
total
cfu
combin
lactobacillu
acidophilu
bacillu
subtili
bifidobacterium
thermophilum
enterococcu
faecium
bifidobacterium
longum
control
calv
given
oral
bolu
probiot
calv
offer
g
powder
asf
nonmed
cp
fat
milk
replac
herdmak
land
olak
anim
milk
product
co
shoreview
mn
twice
daili
h
prophylact
calv
administ
total
cfud
combin
l
acidophilu
b
subtili
b
thermophilum
e
faecium
b
longum
gd
proprietari
blend
mannanoligosaccharid
fructooligosaccharid
activ
charcoal
gd
dri
egg
protein
lay
hen
vaccin
escherichia
coli
antigen
salmonella
typhimurium
salmonella
dublin
coronaviru
rotaviru
ad
directli
milk
replac
calfpro
plu
calf
life
c
e
agri
product
baldwin
nd
daili
prophylact
treatment
divid
half
administ
feed
control
calv
administ
prebiot
probiot
dri
egg
protein
prophylact
calv
consecut
day
fecal
score
given
acidifi
oral
electrolyt
ad
directli
milk
replac
given
addit
dose
total
cfud
combin
l
acidophilu
b
subtili
b
thermophilum
e
faecium
b
longum
control
calv
consecut
day
fecal
score
treat
acidifi
oral
electrolyt
mg
trimethoprim
pfizer
anim
health
new
york
ny
mg
sulfa
pfizer
anim
health
per
kilogram
bw
ad
directli
milk
replac
administr
antibiot
combin
morbid
calv
standard
oper
procedur
dairi
calv
first
wk
life
texa
tech
univers
calf
facil
calf
consecut
day
fecal
score
classifi
morbid
calf
feed
manag
strategi
similar
treatment
group
first
week
calv
offer
ad
libitum
access
calf
starter
tabl
water
daili
intak
calf
starter
calcul
quantiti
starter
offer
minu
daili
refus
sampl
calf
starter
collect
everi
monday
wednesday
friday
composit
week
analys
dm
estim
dm
refus
also
collect
composit
calv
monday
wednesday
friday
dm
measur
calf
starter
refus
use
calcul
dmi
calf
starter
milk
replac
refus
record
calf
min
feed
research
personnel
consid
refus
calf
would
suckl
anymor
calf
starter
intak
measur
daili
fecal
score
classifi
independ
train
observ
multipl
time
daili
accord
guidelin
outlin
larson
et
al
briefli
firm
wellform
hard
soft
puddinglik
runni
pan
within
h
collect
whole
blood
analyz
hematocrit
total
leukocyt
count
differenti
neutrophil
mononuclear
cell
use
cell
dyn
autom
loader
veterinari
softwar
packag
abbot
laboratori
abbot
il
addit
neutrophil
mononuclear
cell
ratio
calcul
plasma
collect
centrifug
g
store
analys
cortisol
glucos
urea
nitrogen
haptoglobin
concentr
plasma
sampl
analyz
duplic
plasma
concentr
cortisol
determin
use
commerci
avail
elisa
arbor
assay
ann
arbor
mi
intraassay
interassay
cv
respect
plasma
concentr
glucos
urea
nitrogen
concentr
analyz
use
commerci
avail
enzymat
kit
stanbio
laboratori
boern
tx
intraand
interassay
cv
assay
respect
plasma
haptoglobin
concentr
determin
measur
haptoglobinhemoglobin
complex
estim
differ
peroxidas
activ
makimura
suzuki
arthington
et
al
result
express
arbitrari
unit
result
absorb
nm
intraand
interassay
cv
respect
ex
vivo
immunolog
method
describ
hulbert
et
al
briefli
simultan
phagocyt
oxid
burst
capac
circul
neutrophil
evalu
respons
enteropathogen
e
coli
isol
spleen
septicem
calf
data
report
percentag
neutrophil
phagocyt
produc
oxid
burst
well
geometr
fluoresc
intens
addit
express
adhes
molecul
lselectin
integrin
circul
neutrophil
determin
data
report
geometr
mean
fluoresc
intens
final
whole
blood
cocultur
final
concentr
lipopolysaccharid
e
coli
sigmaaldrich
st
loui
mo
h
follow
incub
cell
cultur
centrifug
g
supernat
collect
store
analysi
concentr
tumor
necrosi
use
commerci
avail
elisa
r
biosystem
minneapoli
mn
intrapl
cv
innat
immun
respons
evalu
current
studi
chosen
reflect
key
respons
recognit
whole
blood
tumor
necrosi
respons
recruit
express
adhes
molecul
lselectin
integrin
elimin
bacteria
phagocyt
oxid
burst
capac
enteropathogen
e
coli
repeat
continu
data
analyz
restrict
maximum
likelihood
anova
use
mix
procedur
sa
sa
version
sa
inst
inc
cari
nc
model
includ
treatment
day
treatment
day
fix
effect
calf
nest
within
treatment
random
effect
appropri
covari
structur
withincalf
measur
chosen
base
schwartz
bayesian
criterion
nonrep
continu
data
analyz
anova
use
gener
linear
procedur
sa
treatment
fix
effect
furthermor
calv
classifi
scour
consecut
fecal
score
analyz
determin
initi
durat
scour
data
analyz
anova
test
homogen
varianc
normal
use
univari
procedur
sa
enter
morbid
milk
replac
refus
analyz
use
chisquar
probabl
test
use
frequenc
procedur
sa
addit
differ
treatment
frequenc
calv
refus
milk
replac
enrol
sum
milk
replac
refus
calv
milk
replac
refus
analyz
wilcoxon
rank
test
use
procedur
sa
throughout
manuscript
treatment
differ
p
consid
signific
p
consid
tendenc
least
squar
mean
report
throughout
unless
otherwis
note
influenc
supplement
blend
prebiot
probiot
hyperimmun
dri
egg
protein
perform
health
innat
immun
respons
holstein
calv
first
age
investig
studi
conduct
februari
averag
low
high
temperatur
studi
period
respect
enrol
differ
initi
bw
total
serum
protein
treatment
tabl
differ
observ
perform
calv
treatment
tabl
among
calv
neg
adg
first
week
kgd
posit
kgd
result
similar
hill
et
al
wherein
observ
differ
adg
birth
wean
calv
supplement
either
gd
prebiot
fructooligosaccharid
ultrafo
encor
technolog
llc
minneapoli
mn
addit
heinrich
et
al
observ
differ
adg
holstein
calv
supplement
gd
prebiot
biomo
alltech
nicholasvil
ky
howev
observ
postwean
increas
calf
starter
intak
among
calv
fed
prebiot
contrast
present
data
abe
et
al
observ
increas
adg
effici
bw
gain
holstein
calv
either
administ
cfud
probiot
bifidobacterium
pseudolongum
l
acidophilu
milk
replac
addit
cruywagen
et
al
report
supplement
milk
replac
cfud
l
acidophilu
prevent
loss
bw
often
observ
dairi
calv
first
wk
life
contrast
morril
et
al
observ
increas
perform
holstein
calv
supplement
probiot
biomat
chr
hansen
milwauke
wi
howev
observ
increas
perform
portion
protein
milk
replac
replac
spraydri
plasma
either
porcin
bovin
sourc
contrast
quigley
et
al
replac
either
cp
milk
replac
spraydri
bovin
plasma
see
improv
adg
age
present
data
taken
togeth
past
literatur
indic
influenc
prebiot
probiot
well
supplement
protein
perform
holstein
calv
variabl
milk
replac
refus
invers
proport
age
first
life
refus
rare
associ
morbid
calf
influenc
treatment
proport
calv
refus
milk
replac
first
age
vs
control
prophylact
respect
p
howev
among
calv
refus
milk
replac
prophylact
calv
refus
less
milk
replac
period
tabl
therefor
prophylact
treatment
lessen
intens
milk
refus
among
calv
refus
milk
replac
underli
mechan
seemingli
improv
appetit
among
calv
refus
milk
replac
first
life
unknown
could
attribut
less
sever
enter
diseas
enter
morbid
classifi
consecut
day
fecal
score
common
among
control
calv
among
prophylact
calv
tabl
data
consist
literatur
inclus
prebiot
heinrich
et
al
probiot
abe
et
al
et
al
hyperimmun
egg
protein
ikemori
et
al
hennigpauka
et
al
improv
fecal
score
reduc
scour
howev
perform
data
influenc
prebiot
probiot
hyperimmun
protein
enter
health
equivoc
hill
et
al
observ
improv
scour
calv
less
mo
age
milk
replac
supplement
fructooligosaccharid
addit
cruywagen
et
al
observ
improv
incid
enter
morbid
calv
supplement
cfu
l
acidophilu
age
scour
observ
differ
treatment
tabl
scour
nonspecif
symptom
enter
diseas
etiolog
spontan
calf
scour
complex
often
involv
one
infecti
agent
includ
variou
bacteria
virus
parasit
clinic
sign
scour
nonspecif
caus
agent
difficult
ascertain
without
directli
examin
fecal
microbiota
ecolog
age
calf
usual
best
diagnost
indic
e
coli
major
pathogen
first
week
life
rotaviru
cryptosporidiosi
appear
calf
etiolog
second
third
week
life
blood
futur
research
determin
whether
prophylact
treatment
use
current
studi
differ
efficaci
differ
combin
pathogen
age
calf
final
durat
scour
among
calv
develop
scour
differ
treatment
tabl
control
calv
scour
treat
oral
dose
antimicrobi
wherea
scour
prophylact
calv
treat
antimicrobi
instead
administ
addit
dose
probiot
remain
determin
probiot
addit
probiot
enter
diseas
improv
recoveri
diseas
therefor
could
use
altern
therapeut
antimicrobi
treatment
bacteri
scour
children
metaanalysi
influenc
lactobacillu
spp
therapi
treatment
acut
diarrhea
indic
reduct
diarrhea
durat
well
diarrhea
frequenc
van
niel
et
al
howev
probiot
may
equal
effect
children
acut
diarrhea
differ
probiot
evalu
addit
oral
rehydr
therapi
one
probiot
shorten
durat
diarrhea
canani
et
al
therefor
proof
efficaci
probiot
speci
strain
need
determin
research
gener
across
strain
speci
limit
develop
hypothes
treatment
influenc
total
peripher
blood
leukocyt
differenti
count
tabl
addit
differ
hematocrit
plasma
concentr
haptoglobin
cortisol
glucos
urea
nitrogen
tabl
data
indic
prophylact
treatment
influenc
system
physiolog
calv
first
life
reduct
proport
peripher
leukocyt
neutrophil
well
decreas
plasma
haptoglobin
time
data
shown
indic
either
matur
system
physiolog
adapt
calv
ex
utero
environ
determin
whether
agerel
chang
peripher
neutrophil
count
plasma
haptoglobin
concentr
due
lower
immunogen
stimul
reduc
stress
mortal
rate
current
studi
low
one
calf
die
control
calf
addit
calv
treatment
classifi
sever
ill
later
recumb
complet
anoret
old
control
prophylact
respect
therapeut
treatment
sever
ill
calv
includ
ceftiofur
hydrochlorid
excenel
pfizer
anim
health
new
york
ny
flunixin
meglumin
banamin
intervet
scheringplough
subcutan
lactat
ringer
solut
therefor
incid
system
infect
like
low
thu
low
calf
morbid
rate
present
studi
allow
potenti
benefit
system
variabl
mortal
express
futur
research
evalu
potenti
prophylact
treatment
use
current
studi
reduc
mortal
group
highrisk
experiment
challeng
immunocompromis
eg
colostrum
calv
mani
plausibl
mechan
explain
reduc
incid
enter
morbid
milk
replac
fed
calv
supplement
combin
prebiot
probiot
hyperimmun
pro
tein
includ
neutral
potenti
pathogen
bernet
et
al
hennigpauka
et
al
direct
bactericid
activ
midolo
et
al
immun
modul
blum
et
al
lomax
calder
current
studi
influenc
treatment
innat
immun
respons
peripher
leukocyt
holstein
calv
evalu
age
tabl
data
agre
find
letelli
et
al
prebiot
probiot
alon
combin
influenc
peripher
blood
phagocyt
function
neonat
piglet
howev
role
prebiot
probiot
play
immun
modul
inconclus
like
influenc
mani
environment
factor
blum
et
al
lomax
calder
regardless
current
data
indic
benefit
combin
prebiot
probiot
hyperimmun
egg
protein
supplement
reduc
enter
morbid
first
age
like
associ
increas
nonspecif
immun
respons
holstein
calv
prophylact
combin
prebiot
probiot
hyperimmun
egg
protein
reduc
day
spontan
scour
first
age
compar
treatment
nonmed
control
milk
replac
differ
perform
measur
system
health
due
prophylact
treatment
howev
morbid
mortal
rate
low
current
studi
impli
good
gener
calf
manag
futur
research
determin
efficaci
current
prophylact
treatment
calv
higher
risk
develop
sever
morbid
subsequ
mortal
calv
unknown
colostrum
statu
shippingstress
calv
author
thank
c
j
cobb
texa
tech
univers
j
w
dailey
usdaar
livestock
issu
research
unit
lubbock
tx
provid
anim
husbandri
l
e
hulbert
texa
tech
univers
lubbock
provid
laboratori
support
final
land
olak
anim
milk
product
co
shoreview
mn
donat
milk
replac
use
studi
studi
fund
c
e
agri
product
baldwin
nd
